Bayer stock: Q3 results due November 3 as estimates split

Published on 11/01/2026 at 17:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bayer stock enters a key reporting week as JPMorgan sees revenue above consensus but operating profit below expectations. The results will test that split view.

What Bayer investors should watch

Bayer will publish its third-quarter results and quarterly statement before the investor video call.
JPMorgan expects revenue above consensus but sees pharmaceutical and agriculture EBITDA below consensus.
The company has also scheduled management remarks and a question-and-answer session for the reporting day.

Bayer, DE000BAY0017, Illustration mit AI erstellt.

Bayer will publish its third-quarter 2026 results on Tuesday, November 3, putting revenue, operating profit and management's full-year outlook in focus for investors. Bayer's official Q3 2026 Media Update says the news release and quarterly statement will be available from 7:30 a.m. CET.

Revenue and profit expectations diverge

A pre-results assessment from boerse-global.de reports that JPMorgan expects Bayer's revenue to come in 2 percent above consensus. The bank forecasts EBITDA in the pharmaceuticals and agriculture divisions 6 percent below consensus, creating a split setup in which stronger sales would not necessarily translate into a positive operating-profit surprise.

The brokerage reaffirmed its Overweight rating and a 61 euro price target, while expecting Bayer to maintain its full-year guidance. Those are analyst expectations rather than reported results, so the quarterly release will determine whether the projected revenue-profit gap appears in the figures.

Management commentary follows results

Bayer plans a live video broadcast from 10:00 a.m. CET with remarks from CEO Bill Anderson and CFO Judith Hartmann, followed by a question-and-answer session. The company says a recording should be available at approximately 2:00 p.m. CET.

For the broader investment case, the report will also offer a fresh read on the group's pharmaceuticals and agriculture businesses while the company continues to manage litigation exposure linked to Monsanto's Roundup business. The earnings release and management commentary are therefore the week's central catalysts for Bayer investors.

Bayer stock traded at 51.03 euros on Lang & Schwarz at 17:12:35 CET on Sunday, November 1, 2026.

For the real-time quote of Bayer stock, investors can follow the latest trading indication.